Dose-escalation, Repeated and Single Oral Dosing Study
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Randomized, Double-blind, Placebo-controlled, Dose-escalation, Repeated and Single Oral
Dosing Phase I Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of APD791
(Temanogrel) Co-administered with Aspirin and Clopidogrel.